Li-Hsing ChiTaipei Medical University | TMU · Institute for Translational Medicine
Li-Hsing Chi
Doctor of Dental Surgery Ph.D.
D.D.S. and Ph.D. for holistic cancer care and translational medicine
About
10
Publications
1,584
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
83
Citations
Citations since 2017
Introduction
'I love scientific research. And when you have a group of guys that are committed to doing it the right way as we do here, it makes it an, even more, fun job.'
Oral and Maxillofacial surgeon, Taipei Medical University Hospital;
Biomedical Informatics
Additional affiliations
April 2021 - present
March 2012 - December 2021
Education
January 1998 - February 2022
Publications
Publications (10)
Survival analysis of the Cancer Genome Atlas (TCGA) dataset is a well-known method for discovering gene expression-based prognostic biomarkers of head and neck squamous cell carcinoma (HNSCC). A cutoff point is usually used in survival analysis for patient dichotomization when using continuous gene expression values. There is some optimization soft...
Background: The survival analysis of the Cancer Genome Atlas (TCGA) dataset is a well-known method to discover the gene expression-based prognostic biomarkers of head and neck squamous cell carcinoma (HNSCC). In order to utilize a continuous gene expression for survival analysis, it is necessary to determine a cutoff point by the dichotomization of...
Background
The survival analysis of the Cancer Genome Atlas (TCGA) dataset is a well-known method to discover the gene expression-based prognostic biomarkers of head and neck squamous cell carcinoma (HNSCC). In order to utilize a continuous gene expression for survival analysis, it is necessary to determine a cutoff point by the dichotomization of...
Background: The survival analysis of the Cancer Genome Atlas (TCGA) dataset is a well-known method to discover the gene expression-based prognostic biomarkers of head and neck squamous cell carcinoma (HNSCC). In order to utilize a continuous gene expression for survival analysis, it is necessary to determine a cutoff point by the dichotomization of...
Head and neck squamous cell carcinoma (HNSCC) represents a major health concern worldwide. We applied the matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) to analyze paired normal (N) and tumor (T) samples from head and neck squamous cell carcinoma as well as liquid chromatography with tandem mass spectrometry (LC...
Background
Head and neck squamous cell carcinoma (HNSCC) represents a unique and major health concern worldwide. Significant increases in glucose uptake and aerobic glycolysis have been observed in HNSCC cells. Glucose transporters (GLUTs) represent a major hub in the glycolysis pathway, with GLUT4 having the highest glucose affinity. However, GLUT...
Ameloblastic carcinoma, a rare malignant odontogenic tumor, is a highly aggressive tumor with rapid growth and a high potential for distant metastasis. Surgical resection is the most common treatment modality, while there are still controversies about the efficacy of neck dissection, radiotherapy, and chemotherapy. Herein we report a case of amelob...
Le Fort I osteotomy is used as a surgical procedure for correction of maxillofacial deformities. The common complications of this procedure are hemorrhage and infection, with incidence of 6% to 9%. Blindness associated with Le Fort I osteotomy was reported in 8 patients. An 18-year-old female complained of loss of sight in the left eye after recove...
